山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (6): 48-53.doi: 10.6040/j.issn.1671-7554.0.2014.560
周静1,2, 常晓天2, 周婷2, 崔莹莹2, 张蓓2, 荣风年2
ZHOU Jing1,2, CHANG Xiaotian2, ZHOU Ting2, CUI Yingying2, ZHANG Bei2, RONG Fengnian2
摘要: 目的 探讨抑制肽酰基精氨酸脱亚氨酶4(PADI4)对卵巢癌细胞系OVCAR3的影响。方法 PADI4-siRNA组和阴性对照组siRNA分别转染卵巢癌细胞OVCAR3,采用实时定量PCR及Western Blotting检测PADI4、p53和p21的表达, AnnexinⅤ-PE/7-AAD双染和transwell小室法分别检测细胞凋亡、侵袭和迁移的情况。结果 与阴性对照组相比,PADI4-siRNA组的OVCAR3细胞中PADI4表达降低,且其凋亡细胞比例明显增加(P<0.05),细胞侵袭能力明显减弱(P<0.01),但细胞趋化能力没有明显变化。PADI4-siRNA组p53表达较阴性对照组降低,但p21表达并没有降低。结论 沉默PADI4影响卵巢癌细胞OVCAR3凋亡和侵袭特性,提示PADI4参与调控卵巢癌细胞恶性生物学行为。
中图分类号:
| [1] Jemal A, Siegel R, Xu J, et al. Cancer statistics[J]. CA Cancer J Clin, 2010, 60(5): 277-300. [2] Wang L, Chang X, Yuan G, et al. Expression of peptidylarginine deiminase type 4 in ovarian tumors[J]. Int J Biol Sci, 2010, 6(5): 454-464. [3] Liu GY, Liao YF, Chang WH, et al. Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells[J]. Apoptosis, 2006, 11(2): 183-196. [4] Yang Lv, Yan Xia, Yaohua Wang, et al. Expression of PADI4 in hepatocellular carcinoma[J]. Chinese-German Journal of Clinical Oncology, 2009, 8(8):453-455. doi: 10.1007/s10330-009-0058-y. [5] Chang X, Han J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors[J]. Mol Carcinog, 2006, 45(3): 183-196. [6] Chang X, Hou X, Pan J, et al. Investigating the pathogenic role of PADI4 in oesophageal cancer[J]. Int J Biol Sci, 2011, 7(6): 769-781 [7] Chang X, Han J, Pang L, et al. Increased PADI4 expression in blood and tissues of patients with malignant tumors[J]. BMC Cancer, 2009, 9: 40. doi: 10.1186/1471-2407-9-40. [8] Tanikawa C, Ueda K, Nakagawa H, et al. Regulation of protein citrullination through p53/PADI4 network in DNA damage response[J]. Cancer Res, 2009, 69(22): 8761-8769. [9] 罗祎, 姚珍薇, 杨雅莹, 等. 人端粒酶逆转录酶基因 siRNA质粒的构建及其对不同p53状态卵巢癌细胞生长和凋亡的影响[J]. 中国生物制品学杂志, 2013, 26(6): 780-791. LUO Yi, YAO Zhenwei, YANG Yaying, et al. Contstruction of siRNA plasmid for human telomerase reverse transcriptase gene and its effect on growth and apoptosis of ovarian cancer cells in presence or absence of p53[J]. Chinese Journal of Biologicals, 2013, 26(6): 780-791. [10] Mirza A, Wu Q, Wang L, et al. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression[J]. Oncogene, 2003, 22(23): 3645-3654. [11] Zuckerman V, Wolyniec K, Sionov RV, et al. Tumour suppression by p53: the importance of apoptosis and cellular senescence[J]. J Pathol, 2009, 219(1): 3-15. [12] Lee JH, Lee SY, Lee JH, et al. p21WAF1 is involved in interferon-β-induced attenuation of telomerase activity and human telom-erase reverse transcriptase (hTERT) expression in ovarian cancer[J]. Mol Cells, 2010, 30(4): 327-333. [13] Deplus R, Denis H, Putmans P, et al. Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation[J]. Nucleic Acids Res, 2014, 42(13): 8285-8296. [14] Yao H, Li P, Venters BJ, et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis[J]. J Biol Chem, 2008, 283(29): 20060-20068. [15] Li P, Yao H, Zhang Z, et al. Regulation of p53 target gene expression by peptidylarginine deiminase[J]. Mol Cell Biol, 2008, 28(15): 4745-4758. [16] Kim EH, Kim IH, Ha JA, et al. Antistress effect of red ginseng in brain cells is mediated by TACE repression via PADI4[J]. J Ginseng Res, 2013, 37(3): 315-323. [17] Chang X, Fang K. PADI4 and tumourigenesis[J]. Cancer Cell Int, 2010, 10:7. doi: 10.1186/1475-2867-10-7. [18] Guo H, Wu F, Wang Y, et al. Overexpressed ubiquitin ligase cullin 7 in breast cancer promotes cell proliferation and invasion via down-regulating p53[J]. Biochem Biophys Res Commun, 2014, 450(4): 1370-1376. [19] 周静, 郑亚冰, 闫莉, 等. 雌激素及顺铂对卵巢癌细胞A2780PADI4的表达及其细胞增殖的影响[J]. 山东大学学报:医学版, 2014, 52(12): 30-34. ZHOU Jing, ZHENG Yabing, YAN Li, et al. The effects of estrogen and cis-platinum on PADI4 expression and cell proliferation in ovarian cancer cell line A2780[J]. Journal of Shandong University (Health Sciences), 2014, 52(12): 30-34. [20] Spillman MA, Manning NG, Dye WW, et al. Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis[J]. Cancer Res, 2010, 70(21): 8927-8936. [21] Hua K, Feng W, Cao Q, et al. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer[J]. Int J Oncol, 2008, 33(5): 959-967. [22] Park SH, Cheung LW, Wong AS, et al. Estrogen regulates snail and slug in the downregulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha[J]. Mol Endocrinol, 2008, 22(9): 2085-2098. |
| [1] | 王伟 王沂峰 张岭梅 林琼燕 黄菊. 人卵巢癌OVCAR3细胞系中侧群细胞的分离及其成瘤性、侵袭性的实验研究[J]. 山东大学学报(医学版), 2209, 47(6): 8-11. |
| [2] | 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-. |
| [3] | 殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73. |
| [4] | 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31. |
| [5] | 李响,张艺,王雪纯,徐梦超,王月兰. 氧化应激在创伤性脑损伤诱发急性肺损伤中的研究进展[J]. 山东大学学报 (医学版), 2025, 63(2): 118-124. |
| [6] | 李观强,施昱诚,朱可涵,胡波,黄献琛,孙元,李笃信,张喜成. 蜗牛粘液来源的活性肽SK-14促进成纤维细胞的增殖和迁移[J]. 山东大学学报 (医学版), 2025, 63(11): 1-7. |
| [7] | 刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45. |
| [8] | 张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42. |
| [9] | 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61. |
| [10] | 姜子晗,芦兴晨,孙露,赵蕙琛,左丹,马小莉,刘元涛,张玉超. NR4A1通过IκBα/NF-κB通路调控过氧化氢诱导人脐静脉内皮细胞凋亡的机制[J]. 山东大学学报 (医学版), 2024, 62(3): 11-19. |
| [11] | 刘金波,刘凯文,向崇鑫,程雷. 西红花苷对椎间盘退变的保护作用[J]. 山东大学学报 (医学版), 2023, 61(9): 84-93. |
| [12] | 何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10. |
| [13] | 杨元凤,熊高才,黎豫川,罗玉玲,张敬杰. 鹿苓安肾颗粒对慢性肾功能衰竭大鼠炎症反应及细胞凋亡的影响[J]. 山东大学学报 (医学版), 2023, 61(10): 9-16. |
| [14] | 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58. |
| [15] | 张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84. |
|
||